Anti-Microbialvior BioteQ Co (ROCO:6864) EBIT : NT$-74.49 Mil (TTM As of Dec. 2024)

Anti-Microbialvior BioteQ Co EBIT Chart

Anti-Microbialvior BioteQ Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBIT	Get a 7-Day Free Trial						-23.82	-25.52	-31.23	-31.40	-43.09

Competitive Comparison of Anti-Microbialvior BioteQ Co's EBIT

For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anti-Microbialvior BioteQ Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Anti-Microbialvior BioteQ Co's EV-to-EBIT falls into.

Anti-Microbialvior BioteQ Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-74.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anti-Microbialvior BioteQ Co  (ROCO:6864) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Anti-Microbialvior BioteQ Co's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Anti-Microbialvior BioteQ Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Anti-Microbialvior BioteQ Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anti-Microbialvior BioteQ Co EBIT Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Anti-Microbialvior BioteQ Co Business Description